3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
424
Neoplasms
281
Carcinoma, Non-Small-Cell Lung
272
Colorectal Neoplasms
236
Prostatic Neoplasms
173
Lung Neoplasms
172
Carcinoma, Hepatocellular
157
Stomach Neoplasms
126
Leukemia, Myeloid, Acute
120
Pancreatic Neoplasms
118
Multiple Myeloma
106
Recurrence
99
Uterine Cervical Neoplasms
97
Squamous Cell Carcinoma of Head and Neck
89
Neoplasm Metastasis
88
Rectal Neoplasms
87
Ovarian Neoplasms
81
Triple Negative Breast Neoplasms
77
Small Cell Lung Carcinoma
72
Head and Neck Neoplasms
69
Brain Neoplasms
68
Esophageal Neoplasms
65
Glioblastoma
64
Endometrial Neoplasms
60
Colonic Neoplasms
59
Melanoma
55
Hematologic Neoplasms
53
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Motor Activity
48
Carcinoma, Renal Cell
47
Interventions
lenvatinib
1
camrelizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Interventional
×
Advanced Triple Negative Breast Cancer
×
Clear all
NCT06849492
2025-02-27
SHIFT-001
Fudan University
Phase 2
Not yet recruiting
120 enrolled